leqembi data is solid. 2 infusion sites. both full.
Company: Biogen
Tags: field, strategy, launch
CLARITY AD 18-month data is compelling. neurologists who read it believe it. but I'm detailing a drug to accounts that can't operationally use it. that's an access infrastructure problem. not a clinical story problem. need site development support not more leave-behinds
9 upvotes · 5 comments